Skip to Main Content

Massachusetts General Hospital will soon start the first clinical trial that simultaneously tests multiple potential ALS medicines in the hopes of getting results faster at lower costs.

The Boston teaching hospital plans to launch the first “platform trial” in early 2020 at the Sean M. Healey & AMG Center for ALS, which was founded last year with $40 million in donations. The trial will be run by MGH, start off with five medicines, and take place at 54 clinical sites in the country.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!